Bisphosphonates for osteoporosis treatment with non metastatic prostate cancer

{
  "compose" : {
    "exclude" : [ ],
    "include" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "extension" : [ {
        "extension" : [ {
          "valueString" : "concept",
          "url" : "path"
        }, {
          "url" : "count",
          "valueInteger" : 12
        } ],
        "url" : "http://health-samurai.io/extensions/excised-data"
      } ]
    } ]
  },
  "date" : "2017-06-21T01:00:04-04:00",
  "meta" : {
    "versionId" : "4",
    "lastUpdated" : "2017-06-21T01:00:04.000-04:00",
    "profile" : [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ]
  },
  "publisher" : "LUGPA Steward",
  "jurisdiction" : [ {
    "extension" : [ {
      "valueString" : "UNKNOWN",
      "url" : "http://hl7.org/fhir/StructureDefinition/data-absent-reason"
    } ]
  } ],
  "purpose" : "(Clinical Focus: This set of values contains bisphosphonates that are prescribed for osteoporosis in men with prostate cancer that is non metastatic to bone.),(Data Element Scope: The intent of this data elemnt is to identify bisphosphonates for treatment of osteoporosis in men with prostate cancer that is not metastatic to the bone.),(Inclusion Criteria: Bisphosphonates for use with men with osteoporosis),(Exclusion Criteria: Bisphosphonates not approved for men with prostate cancer on androgen deprivation therapy)",
  "name" : "BisphosphonatesForOsteoporosisTreatmentWithNonMetastaticProstateCancer",
  "experimental" : false,
  "resourceType" : "ValueSet",
  "expansion" : {
    "contains" : [ {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1020064",
      "display" : "risedronate sodium 35 MG Delayed Release Oral Tablet",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1114085",
      "display" : "100 ML zoledronic acid 0.04 MG/ML Injection",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1248077",
      "display" : "alendronic acid 70 MG Effervescent Oral Tablet",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1435115",
      "display" : "28 ACTUAT teriparatide 0.02 MG/ACTUAT Pen Injector",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "1865665",
      "display" : "zoledronic acid 4 MG Injection",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "351114",
      "display" : "5 ML zoledronic acid 0.8 MG/ML Injection",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "705824",
      "display" : "100 ML zoledronic acid 0.05 MG/ML Injection",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "904419",
      "display" : "alendronic acid 10 MG Oral Tablet",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "904431",
      "display" : "alendronic acid 70 MG Oral Tablet",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "904462",
      "display" : "alendronic acid 70 MG / cholecalciferol 5600 UNT Oral Tablet",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "904492",
      "display" : "alendronic acid 70 MG / cholecalciferol 2800 UNT Oral Tablet",
      "version" : "06052023"
    }, {
      "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
      "code" : "905024",
      "display" : "risedronate sodium 35 MG Oral Tablet",
      "version" : "06052023"
    } ],
    "offset" : 0,
    "total" : 12,
    "identifier" : "urn:uuid:b4860b3c-749b-4ee4-94d8-5e198d7ae063",
    "timestamp" : "2023-06-29T15:57:56-04:00",
    "parameter" : [ {
      "name" : "count",
      "valueInteger" : 1000
    }, {
      "name" : "offset",
      "valueInteger" : 0
    } ]
  },
  "title" : "Bisphosphonates for osteoporosis treatment with non metastatic prostate cancer",
  "extension" : [ {
    "valueString" : "LUGPA Author",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author"
  }, {
    "valueDate" : "2022-12-15",
    "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate"
  }, {
    "valueDate" : "2017-06-21",
    "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate"
  }, {
    "url" : "http://health-samurai.io/extensions/source",
    "valueCode" : "db"
  } ],
  "status" : "active",
  "id" : "a3840b00-b008-49b6-8603-d0a3769eacda",
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.30",
  "identifier" : [ {
    "system" : "urn:ietf:rfc:3986",
    "value" : "urn:oid:2.16.840.1.113762.1.4.1164.30"
  } ],
  "version" : "20170621"
}